Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."

February 9, 2018

US Bioservices now dispenses BIKTARVY

The U.S. Food and Drug Administration has approved BIKTARVY (bictegravir, emtricitabine, tenofovir alafenamide) for the treatment of adults with HIV-1 infection.